These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22460964)

  • 1. Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus.
    Hull MW; Rollet K; Odueyungbo A; Saeed S; Potter M; Cox J; Cooper C; Gill J; Klein MB;
    Clin Infect Dis; 2012 Jun; 54(12):1798-805. PubMed ID: 22460964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
    Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
    J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
    Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
    Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients.
    McGovern BH; Golan Y; Lopez M; Pratt D; Lawton A; Moore G; Epstein M; Knox TA
    Clin Infect Dis; 2007 Feb; 44(3):431-7. PubMed ID: 17205454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
    Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
    J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.
    Macias J; Japón MA; Sáez C; Palacios RB; Mira JA; García-García JA; Merchante N; Vergara S; Lozano F; Gómez-Mateos J; Pineda JA
    J Infect Dis; 2005 Nov; 192(9):1566-76. PubMed ID: 16206071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stronger hepatitis C virus-specific CD8+ T-cell responses in HIV coinfection.
    Barrett L; Gallant M; Howley C; Ian Bowmer M; Hirsch G; Peltekian K; Grant M
    J Viral Hepat; 2011 Mar; 18(3):170-80. PubMed ID: 20497309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
    Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
    J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
    Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
    AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of portal pressure on the discordance between absolute CD4+ cell count and CD4+ cell percentage in HIV/hepatitis C virus-coinfected patients.
    Mandorfer M; Reiberger T; Payer BA; Peck-Radosavljevic M;
    Clin Infect Dis; 2013 Mar; 56(6):904-5. PubMed ID: 23243175
    [No Abstract]   [Full Text] [Related]  

  • 12. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
    Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
    J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.
    Moore DM; Hogg RS; Braitstein P; Wood E; Yip B; Montaner JS
    Antivir Ther; 2006; 11(1):125-9. PubMed ID: 16518968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
    Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
    Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection.
    Alatrakchi N; Graham CS; He Q; Sherman KE; Koziel MJ
    J Infect Dis; 2005 Mar; 191(5):702-9. PubMed ID: 15688283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.
    Puoti M; Bonacini M; Spinetti A; Putzolu V; Govindarajan S; Zaltron S; Favret M; Callea F; Gargiulo F; Donato F; Carosi G;
    J Infect Dis; 2001 Jan; 183(1):134-7. PubMed ID: 11087200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosis.
    Claassen CW; Diener-West M; Mehta SH; Thomas DL; Kirk GD
    Clin Infect Dis; 2012 Jun; 54(12):1806-13. PubMed ID: 22460963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
    Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
    Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
    Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
    Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.